Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association
M McClellan, N Brown, RM Califf, JJ Warner - Circulation, 2019 - Am Heart Assoc
Although advances in care have spurred improvements in cardiovascular outcomes,
cardiovascular disease remains the leading cause of death in the United States and around …
cardiovascular disease remains the leading cause of death in the United States and around …
Multiplexed sensing techniques for cardiovascular disease biomarkers-A review
Cardiovascular diseases (CVDs) are the number one cause of death worldwide, taking 17.9
million lives each year. The rapid, sensitive, and accurate determination of cardiac …
million lives each year. The rapid, sensitive, and accurate determination of cardiac …
Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association
RA Harrington, RM Califf, A Balamurugan, N Brown… - Circulation, 2020 - Am Heart Assoc
Understanding and addressing the unique health needs of people residing in rural America
is critical to the American Heart Association's pursuit of a world with longer, healthier lives …
is critical to the American Heart Association's pursuit of a world with longer, healthier lives …
Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017
Background: Medication nonadherence is associated with worse outcomes in patients with
atherosclerotic cardiovascular disease (ASCVD), a group who requires long-term therapy for …
atherosclerotic cardiovascular disease (ASCVD), a group who requires long-term therapy for …
Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions
Atherosclerotic cardiovascular disease (ASCVD) has posed an increasing burden on
Americans and the United States healthcare system for decades. In addition, ASCVD has …
Americans and the United States healthcare system for decades. In addition, ASCVD has …
Trends in cardiovascular disease prevalence by income level in the United States
Importance Income disparity between persons with the most resources (the top 20% of
earners) and the remainder of the population in the United States has dramatically widened …
earners) and the remainder of the population in the United States has dramatically widened …
Financial burden, distress, and toxicity in cardiovascular disease
Cardiovascular disease (CVD) is a major source of financial burden and distress, which has
3 main domains:(1) psychological distress;(2) cost-related care non-adherence or medical …
3 main domains:(1) psychological distress;(2) cost-related care non-adherence or medical …
Out‐of‐pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States
SY Wang, J Valero‐Elizondo, HJ Ali… - Journal of the …, 2021 - Am Heart Assoc
Background Heart failure (HF) poses a major public health burden in the United States. We
examined the burden of out‐of‐pocket healthcare costs on patients with HF and their …
examined the burden of out‐of‐pocket healthcare costs on patients with HF and their …
Out-of-pocket spending and financial burden among low income adults after Medicaid expansions in the United States: quasi-experimental difference-in-difference …
Objective To examine the association between expansion of the Medicaid program under
the Affordable Care Act and changes in healthcare spending among low income adults …
the Affordable Care Act and changes in healthcare spending among low income adults …
Premature Ticagrelor Discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review Topic of the Week
Ticagrelor is a cornerstone of modern antithrombotic therapy alongside aspirin in patients
with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects …
with acute coronary syndrome and after percutaneous coronary intervention. Adverse effects …